Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Regulatory News

NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk

November 13, 2026
Vol.52 No.42
By Claire Marie Porter
ACS CAN urges lawmakers to increase NCI funding in next appropriations bill
Cancer Policy

ACS CAN urges lawmakers to increase NCI funding in next appropriations bill

November 13, 2026
Vol.52 No.42
By Sara Willa Ernst
Color Health collaborates with eight NCI-designated cancer centers to cut specialist wait times
In Brief

Color Health collaborates with eight NCI-designated cancer centers to cut specialist wait times

November 13, 2026
Vol.52 No.42
Community sites have the patients to boost trial enrollment—but not the infrastructure
Sponsored

Community sites have the patients to boost trial enrollment—but not the infrastructure

November 06, 2026
Vol.52 No.41
By Gordon Harris
Philip Castle named NCI associate director for prevention
In Brief

Philip Castle named NCI associate director for prevention

November 06, 2026
Vol.52 No.41
CRC incidence rates are rising among all age groups, SEER data analysis finds
Clinical Roundup

CRC incidence rates are rising among all age groups, SEER data analysis finds

November 06, 2026
Vol.52 No.41
NCI’s new CCSG is the result of “thousands of hours” of listening, negotiations, surprises
NCI

NCI’s new CCSG is the result of “thousands of hours” of listening, negotiations, surprises
New NOFO aims to shrink applications by 40%

October 30, 2026
Vol.52 No.40
By Paul Goldberg
NCAB ad hoc working group seeks to define its role as it approves eight reissue concepts
NCI

NCAB ad hoc working group seeks to define its role as it approves eight reissue concepts
“We could do a lot more than be another committee to check the RFAs before they go to the next level.”

October 30, 2026
Vol.52 No.40
By Jacquelyn Cobb
Dinah Singer retires from NCI, remains at NIH as Scientist Emeritus
In Brief

Dinah Singer retires from NCI, remains at NIH as Scientist Emeritus

October 30, 2026
Vol.52 No.40
University of Illinois’ Andrei Gartel receives NCI grant to study AML
In Brief

University of Illinois’ Andrei Gartel receives NCI grant to study AML

October 30, 2026
Vol.52 No.40

Posts navigation

12…41Next

Trending Stories

  • NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
    Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk
  • Is it time to re-assess the practice and practicality of screening colonoscopy?
    Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives
  • ACS strengthens recommendation for prostate cancer screening
    Many will hear the endorsement and ignore the limitations
  • From “default dead” to living the future of cancer care
    As founding CEO of GitLab, I went “founder mode” on my osteosarcoma
  • CMS rule cuts overall oncology payments by estimated 2%
    Final rule slashes 340B, moves toward site-neutrality
  • Kay “Taddy” Dickersin, NBCC co-founder, dies at 74

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account